Introduction {#S0001}
============

Rapamycin is an antibiotic, anti-cancer, and immunosuppressant compound that can induce cancer cell death by inhibiting the activity of the mammalian target of rapamycin (mTOR). Cancer cells often use the mTOR pathway as a mechanism to enhance their proliferation and growth. Also, mTOR signaling plays a key role in the autophagy process in tumor cells. Thus, the inhibitory effect of rapamycin on the mTOR activity may enhance the autophagy flux in cells and decrease tumor growth. Furthermore, it has been reported that rapamycin not only promotes the formation of new autophagosomes but also induces autophagosome-lysosome fusion.[@CIT0001]--[@CIT0004] Evolutionarily, autophagy has been known as a conserved catabolic manner related to the sequestration and transport of organelles and proteins to the lysosomes for degradation. Autophagy is initiated by way of formation of the phagophore or isolated membrane (nucleation), which expands (elongation) and fuses to form a double-membrane structure termed autophagosome. Then after, autophagosomes fuse with lysosomes in order to degrade their content. The autophagy requires numerous conserved proteins, most of them known as autophagy-related proteins (Atgs), functioning at different stages of this process.[@CIT0005]--[@CIT0008]

Apoptosis and autophagy are activated in response to hypoxia, starvation, and endoplasmic reticulum (ER) stress-inducing chemical substances. Thus, they can lead to remov﻿ing damaged organelles, protein aggregates, and invading pathogens. In addition, autophagy may initially be caused to defend the cells by using sequestering and degrading the damaged organelles. Therefore, as soon as a certain level of intracellular harm is reached, apoptosis and autophagy may serve to eliminate the damaged cells from most cancer tissues by cell death induction.

So, because of rapamycin effect on mTOR activity as one of the key factors involved in cancer cell autophagy and growth,[@CIT0009]--[@CIT0011] we aimed to investigate this drug effect on cervical cancer in both hypoxia and normoxia condition.

Materials and Methods {#S0002}
=====================

Chemicals and Reagents {#S0002-S2001}
----------------------

Primary Antibodies were rabbit anti-HIF-1α (Santa Cruz, USA). Acridine orange and rapamycin were obtained from Sigma and Invivogen, respectively. Quantitative RT-PCR using Takara Kit was purchased Takara (Japan). All other reagents were obtained from Sigma-Aldrich (Taufkirchen, Germany)

Cell Culture {#S0002-S2002}
------------

The HeLa cell line was obtained from the Pasteur Institute of Iran. The cells were cultured in DMEM-F12 medium with 10% fetal bovine serum, 100 μg/mL streptomycin and 100 U/mL penicillin. Cells were maintained at 37°C in a humidified CO~2~ incubator (5% CO~2~). Twelve hours before treatment, cells were seeded into a 24-well plate at a density of 1--2 × 10^5^ cells per well. The HeLa cell culture dishes were placed into a hypoxia chamber inside the cell culture incubator and exposed to hypoxia (1% oxygen). Hypoxia was obtained by flushing, low oxygen gas (by injecting nitrogen to displace oxygen). Another set of cell culture dishes were cultured under normoxic condition.

Cell Viability Assay {#S0002-S2003}
--------------------

HeLa cells were seeded at 5 × 10^3^ cells per well in a 96-well culture plate with 10% fetal bovine serum (FBS). After 24 h, cells were treated with 100, 200 and 400 nM of Rapamycin in both hypoxic and normoxic conditions. After 48 and 72 htreatment, MTT assay was done as discussed below. The cells were pulsed with 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT, Sigma, USA) 20 μL/well \[5 mg/mL in PBS\] to measure cell viability. The purple-blue MTT formazan precipitate was dissolved in 200 μL of DMSO and swirled for 30 min. Thereafter, absorbance was measured at 570 nm, with background subtraction of 630 nm using an enzyme-linked immunosorbent assay (ELISA) plate reader. The experiments were repeated six times.

QRT-PCR {#S0002-S2004}
-------

Total RNA samples were extracted from the cells using Trizol reagent (Invitrogen), by the supplier protocol. Forward and reverse primers of target genes were designed by an acceptable primer design software. qRT-PCR was performed on RNA samples using Takara Kit by Rotor Gene 6000 system (Corbett Research, Australia) in a 96-well plate (15 min at 95°C, 40 cycles of 15 s at 95°C, 15 s at 58°C and 20 s at 72°C). Finally, melting was done at 60--95°C (at an increment of 0.5°Cper step and a holding time of 5 s for each step). Relative quantification analysis was performed using the Relative expression software tool (REST). This analysis used the sample's crossing point, the efficiency of the reactions, the number of cycles completed and other values to compare the samples and create the ratios, and results were reported as a normalized ratio. The following primers were used for real-time RT-PCR listed in [Table 1](#T0001){ref-type="table"}.Table 1Primers Used for Real-Time RT-PCRTarget GenePrimer SequenceAmplicon Size (bp)Beclin 1F: 5ʹ-AGCTGCCGTTATACTGTTCTG-3ʹ R: 5ʹ- ACTGCCTCCTGTGTCTTCAATCTT-3'185Bnip3F: 5ʹ-CCACCTCGCTCGCAGACACCAC-3ʹ R: 5ʹ-GAGAGCAGCAGAGATGGAAGGAAAAC-3'317Bnip3LF: 5ʹ-GGACAGAGTAGTTCCAGAGGCAGTTC-3ʹ R: 5ʹ-GGTGTGCATTTCCACATCAAACAT-3'90LC3AF: 5ʹ-CGTCCTGGACAAGACCAAGT-3ʹ R: 5ʹ-CTCGTCTTTCTCCTGCTCGT-3'181LC3BF: 5ʹ-AGCAGCATCCAACCAAAATC-3ʹ R: 5ʹ-CTGTGTCCGTTCACCAACAG-3'187Atg5F: 5ʹ-TGGATTTCGTTATATCC CCTTTAG-3ʹ R: 5ʹ-CCTAGTGTGTGCAACTGTCCA-3'108Bcl-2F: 5ʹ-TTGTGGCCTTCTTTGAGTTCGGTG-3ʹ R: 5ʹ-GGTGCCGGTTCAGGTACTCAGTCA-3'114BaxF: 5ʹ-CCTGTGCACCAAGGTGCCGGAACT-3ʹ R: 5ʹ-CCACCCTGGTCTTGGATCCAGCCC-3'99Beta ActinF: 5ʹ-CAACTGGGACGACATGGAGAAAAT-3ʹ R: 5ʹ-CCAGAGGCGTACAGGGATAGCAC-3'207[^1]

Western Blot {#S0002-S2005}
------------

Cell lysates were incubated in 0.075 M Tris buffer (pH 7.6) and 9 M urea. Bradford's method was used to assess protein concentration of cell lysates, and finely 40 μg of total proteins was separated by 8--10% gel SDS-PAGE under reducing conditions. Then, sample proteins were transferred to a polyvinylidene fluoride membrane (PVDF). The membrane was incubated with a blocking buffer (PBS containing 5% non-fat milk) for 2 h at 25°C. Thereafter, they were immunoblotted with respective primary antibodies and then incubated with specific secondary antibodies. After washing, HIF-1α was detected using a horseradish peroxidase-conjugated reaction. Protein levels were normalized relative to β-actin protein levels. The results were analyzed with TotalLab2 software (Wales, UK).

Acidic Vesicle Detection {#S0002-S2006}
------------------------

Detection of acidic vesicle formation during autophagy was performed by acridine orange staining protocol followed by fluorescence analysis in normoxic and hypoxic conditions with or without rapamycin. In brief, HeLa cells were washed with PBS, fixed in 4% paraformaldehyde for 15 min at room temperature, and then stained with 1 μg/μL of acridine orange for 30 min in the dark. Acridine orange can accumulate in acidic compartments, emitting bright red fluorescence by fluorescence microscopy (Nikon, Japan, TS100), the intensity of which is proportional to the degree of acidity and volume of the compartment and showed autophagy amount.

Acridine Orange-Propidium Iodide (PI) Staining {#S0002-S2007}
----------------------------------------------

eLa cells were seeded in 24-well tissue culture plates (5×10^5^ cells/well), treated with or without Rapamycin (50, 100 and 150 *nM*) for 48 h under normoxia or hypoxia and the cells were washed twice with PBS. Then, the cells were stained with a mixture of acridine orange (3 μg/mL) and propidium iodide (10 μg/mL) and observed immediately using a fluorescence microscope (Nikon-TS100, Japan).

Statistical Analysis {#S0002-S2008}
--------------------

Continuous variables were presented as means ± SD, and statistical comparisons were made by the independent samples *t*-test, one-way ANOVA followed by the Tukey's test. Statistical analyses were performed by GraphPad Prism software v6.0 (GraphPad Software, San Diego, California, USA). Any *P*-value \<0.05 was considered to be statistically significant. Each point or column represents the mean ± SD (n = 4--6). \**P* \< 0.05, \*\* *P* \< 0.01, \*\*\**P* \< 0.001.

Results {#S0003}
=======

HIF-1α Expression {#S0003-S2001}
-----------------

Western blot analysis was used for HIF-1α protein level evaluation in the HeLa cells under hypoxia (1% O~2~) and normoxia (20% O~2~). Results showed that HIF1-α amount significantly increased after 48 h of incubation in hypoxia condition in comparison with the cells in normoxia ([Figure 1](#F0001){ref-type="fig"}).Figure 1Analysis of HIF-1α protein level in Hela cells. Quantification of the protein bands in Western blot analysis carried out using densitometric analysis (TotalLab software, Wales, UK). Protein amounts were normalized against beta-actin and compared with the control. Each data point was presented as mean ± SD from 3 independent experiments. \*\**P* \< 0.01.

Rapamycin Increases Autophagy in HeLa Cells Under Hypoxia Rather Than Normoxia {#S0003-S2002}
------------------------------------------------------------------------------

To detect autophagy amount, HeLa cells were treated with 100 nM and 200 nM of rapamycin for 48 h under normoxic and hypoxic conditions. Then, autophagy related-genes (Atgs) such as Beclin 1, Bnip3, Bnip3L, LC3A, LC3B and Atg5 mRNA levels were assessed by qRT-PCR in the presence or absence of rapamycin. Related results showed increased expressions of Beclin 1, Atg5, LC3A and LC3B in rapamycin-treated HeLa cells compared with untreated cells in normoxia and hypoxia. LC3A and LC3B mRNA expression levels were much higher in rapamycin-treated HeLa cells compared with untreated ones in the normoxia ([Figure 2](#F0002){ref-type="fig"}). Basal Atgs expression increased under normoxia and hypoxia in the presence of rapamycin. mRNA levels of Bnip3 and Bnip3L were elevated in rapamycin-treated cells in hypoxia but not in normoxia. Therefore, the expression of two mentioned genes was significantly increased in rapamycin-treated cells in hypoxia compared with untreated cells and the same results obtained by comparison of rapamycin-treated in normoxia with treated cells in hypoxia. It seems it was due to the different effects of rapamycin on Bnip3 and Bnip3L under hypoxia compared with normoxia. These data indicate the main role for rapamycin as a positive inducer of autophagy during hypoxia rather than normoxia. Rapamycin led to modest but significant up-regulation of Atg levels in HeLa cells in normoxia while, Atg levels were much higher in treating cells under hypoxia in two rapamycin concentrations ([Figure 2A](#F0002){ref-type="fig"}, [B](#F0002){ref-type="fig"}, [D](#F0002){ref-type="fig"} and [E](#F0002){ref-type="fig"}). Furthermore, a comparison of the rapamycin-treated cells in normoxia with treated-cells in hypoxia showed an increased mRNA in autophagy-related genes in both 100 nm and 200 nM rapamycin concentrations ([Figure 2C](#F0002){ref-type="fig"} and [F](#F0002){ref-type="fig"}).Figure 2Real-time PCR Analysis of autophagy-related genes. (**A**--**C**) Real-time PCR Analysis of autophagy-genes such as Beclin 1, ATG-5, Bnip3, Bnip3L, LC3A and LC3B, in HeLa cells under normoxia and hypoxia for 48 h with or without 100 nM Rapamycin treatment. (**D**--**F**) Real-time PCR Analysis of Autophagy-Related Genes such as Beclin 1, ATG-5, Bnip3, Bnip3L, LC3A and LC3B, in HeLa cells under normoxia and hypoxia for 48 h with or without 200 nM Rapamycin treatment each data point was presented as mean ± SD from 3--4 independent experiments. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001.

Furthermore, acridine orange analysis showed an increased autolysosome amount in HeLa cells under rapamycin treatment. The cytoplasmic orange compartment (autolysosome) was much higher in rapamycin-treated HeLa cells incubated in hypoxia rather than normoxia ([Figure 3](#F0003){ref-type="fig"}).Figure 3Autophagosome formation in HeLa cells. Acridine Orange analysis of HeLa cells with or without 200 nM Rapamycin in both normoxic and hypoxic conditions.**Abbreviations:** H+H, HeLa-Hypoxia; H+N, HeLa-Normoxia; Rapa, Rapamycin.

Rapamycin Induced Apoptosis in HeLa Cells Under Hypoxia Rather Than Normoxia {#S0003-S2003}
----------------------------------------------------------------------------

In order to determine rapamycin effect on chromatin condensation and fragmentation, as morphological features of apoptosis, HeLa cells were treated with 100 nM and 200 nM of rapamycin for 48 h under normoxia and hypoxia. As shown in control (no drug treatment) HeLa cells were stained with uniform green fluorescence and no apoptotic features were observed using acridine orange-PI staining. Following rapamycin treatment of cells for 48 h, obvious morphological changes and green apoptotic HeLa cells containing apoptotic characteristics such as cell blebbing and chromatin condensation were observed ([Figure 4A](#F0004){ref-type="fig"}). The results suggest that rapamycin induced HeLa cell apoptosis. Furthermore, rapamycin effect on apoptosis-related genes including Bcl-2 and Bax expression was assessed by real-time PCR. This finding showed an increased Bax-Bcl-2 ratio in rapamycin-treated cells in comparison with control ([Figure 4B](#F0004){ref-type="fig"}). Since autophagy and apoptosis have a close cross-talk together, it seems that apoptosis induction is partly due to autophagy activation in rapamycin-treated HeLa cells.Figure 4Rapamycin induces cell death in HeLa cells. (**A**) Acridine orange-PI staining in Hela cells incubated for 48 h under hypoxia and normoxia with or without rapamycin (100 and 200 nM). Increased orange staining is indicative of cell death induction. (**B**) Real time-PCR Analysis of apoptosis-related genes such as Bax and Bcl-2 in Rapamycin-treated cells compared with untreated cells was incubated under normoxic and hypoxic conditions for 48 h. \*P \< 0.05 and \*\*P \< 0.01.**Abbreviations:** Via, Viable cell; Apo, Apoptotic cell; Nec, Necrotic cell; CB, Cell blebbing; CC, Chromatin condensation; H+H, HeLa-Hypoxia; H+N, HeLa-Normoxia; Rapa, Rapamycin.

Rapamycin Reduces Cell Viability in HeLa Cells Under Hypoxia in Comparison with Normoxia {#S0003-S2004}
----------------------------------------------------------------------------------------

The cell viability of HeLa cells was tested using MTT assays. At the normoxia, changes in cell proliferation or survival of rapamycin-treated cells did not significant. The viability of HeLa cells treated with 100 nM/l of rapamycin in normoxia was 85% greater than untreated cells. In 200 and 400 nM of rapamycin, the viability of treated cells under normoxia was lower than control (80% and 70%, respectively) which indicat﻿es that rapamycin treatment in normoxia was moderately cytotoxic to HeLa cells ([Figure 5A](#F0005){ref-type="fig"}).Figure 5Rapamycin reduced cell viability in HeLa cells. (**A**) Cell viability amount analyzed by MTT assay in rapamycin-treated cells compared with control after 48-h incubation with 100, 200, 400 nM rapamycin in normoxia. (**B**) Cell viability amount analyzed by MTT assay in rapamycin-treated cells compared with control after 48-h incubation with 100, 200, 400 nM in hypoxia. n = 3, mean ± SD, \*\**P* \< 0.01, \*\*\**P* \< 0.001.

The viability of treated cells with 100, 200 and 400 nM rapamycin under hypoxia was lower than 75%, 65% and 60%, respectively, in comparison with control, indicating that rapamycin treatment in hypoxia was more cytotoxic to HeLa cells ([Figure 5B](#F0005){ref-type="fig"}). We observed decreased cell viability in HeLa cells with rapamycin in hypoxia compared with control rather than rapamycin-treated cells within normoxia in two rapamycin concentrations. We have found that cells that incubated for 48 h and treatment by 100 and 200 nM/l rapamycin decreased the proliferation amount under hypoxia rather than normoxia. Comparison of the rapamycin-treated cells in hypoxia with treated-cells in normoxia showed a lower survival rate indicating that rapamycin induced cell death by hypoxia is higher than normoxia. Since autophagy induction can lead to apoptosis promotion via pro-apoptotic molecules such as Bnip3, Bnip3L and Atg5 as a cell dead inducer molecule,[@CIT0012],[@CIT0013] it seems that rapamycin has the main role in hypoxia-induced cell death through autophagy induction.

Discussion {#S0004}
==========

Rapamycin as an anti-cancer drug can effect cell viability and growth by inhibition of mTOR activity and signaling. mTOR is one of the important factors in autophagy regulation which its inactivation can result in cancer cell death. Autophagy, a protein and organelle degradation mechanism is a critical process in normal development and responds to environmental stress.[@CIT0014] However, there are opposite reports claiming autophagy can induce cell survival or death.[@CIT0013],[@CIT0015],[@CIT0016] So, in the present study, we investigated the mechanisms by which rapamycin promotes autophagy by mTOR inactivation and the role of autophagy in cancer cell death under normoxic and hypoxic conditions.

Autophagy is a multistep process that each of them is controlled by autophagy-related genes (Atgs) such as Beclin 1, Bnip3, BNIP3L, Bcl-2, Atg5, LC3A and LC3B. Furthermore, it has been indicated that most of these genes are controlled by hypoxia and HIF-1 activity. Hypoxia effect on autophagy has been indicated by its impact on some anti-apoptotic factors including Bcl-2.[@CIT0017]

The BNIP3L gene, belonging to the Bcl-2 (BH3-Only) family, can induce autophagy cell death.[@CIT0018] This gene's product is involved in the pathobiology of various diseases like cancer. The modulated expression of BINP3L during tumor hypoxia can directly influence tumor growth.[@CIT0019] Expression of BNIP3 and BNIP3L is required for an optimum autophagy induction in hypoxic conditions needed their BH3 domains assists in competitively separating Beclin1 from Beclin-Bcl-2 and Beclin-BCL-xL complexes.[@CIT0020]--[@CIT0022] BNIP3 and BNIP3L are proteins with pro-apoptotic effects. Studies have shown that silencing BNIP3 gene is directly associated with tumor growth and development under hypoxic condition. Tumors with severe decrease or the lack of BNIP3 protein are highly metastatic to the lymph nodes and have a higher mitotic index. BNIP and BNIP3L proteins interfere with the anti-apoptotic effects of Bcl-2 and BCL-xL and induce apoptosis. Up-regulation of pro-apoptotic molecules such as the aforementioned molecules can induce both autophagy and apoptosis. Moreover, BNIP3 induces hypoxia autophagic cell death in apoptosis-competent cells such as HeLa cells.[@CIT0011],[@CIT0023],[@CIT0024]

The LC3A/B presents in both outer and inner membrane of autophagosome, so the expression level of this protein is in balance with autophagosome formation level in mammalian cells[@CIT0025] The ATG5 induces autophagy-dependent cell death and LC3-I to LC3-II conversion. ATG5, regard as an autophagy-dependent cell death inducer, also plays a significant role in apoptosis by acting at the downstream of caspases.[@CIT0026] Other studies have proved that increased ATG5 activates apoptosis through calpain activation. Therefore, the studies have defined two autophagy-mediated pathways for cancer cell death in hypoxia, which are dependent on ATG5, interplayed with endoplasmic reticulum and mitochondria, and tightly regulated by hypoxic condition. In addition, both pathways can also require ATG5-mediated LC3-I to LC3-II conversion.[@CIT0011],[@CIT0027],[@CIT0028] In the present study up-regulation of autophagy-related genes (Atgs) such as Beclin 1, Bnip3, Bnip3L, Atg5, LC3A, LC3B were shown in rapamycin-treated HeLa cells compared with untreated cells. These findings demonstrated Atgs over-induction in rapamycin-treated cells, especially in hypoxia.

Furthermore, we provide evidence that autophagy induction results in an increased amount of apoptotic and non-apoptotic death in response to rapamycin treatment. Mechanistically, rapamycin regulates autophagy by both inducing LC3s expression and inactivating mTOR, which might be indirect.[@CIT0029] Previously, mTOR inhibitors were demonstrated to both increase and decrease the transcriptional expression of certain genes. The mTOR inhibitors can promote cell-cycle arrest by increasing the expression of the cell-cycle inhibitor genes. In the case of LC3s, we observed a transcription-dependent increase in LC3B levels induced by rapamycin.[@CIT0030]--[@CIT0032] We have detected that rapamycin-treated HeLa cells decreased the cell viability under hypoxia rather than normoxia using MTT assay. It has been found that the lower cell viability in treating cells under hypoxia compared with the same under normoxia is partly due to autophagy induction. Acridine orange analysis showed an increased autolysosome in HeLa cells under rapamycin treatment, especially in hypoxia. Due data showed an increased Bax-Bcl-2 ratio in rapamycin-treated cells in comparison with control, and apoptosis amount in rapamycin-treated cells was elevated in comparison with untreated cells using acridine orange-PI analysis.

There are few studies concerning the therapeutic efficacy of rapamycin in cervical cancer so, in the present study, we examined this drug effect on HeLa cells. It was shown that rapamycin induces cervical cancer cells death by modulating autophagy and regulating the expression of Atgs and Bcl-2 family proteins, especially in tumor hypoxia ([Figure 6](#F0006){ref-type="fig"}). However, HIF1-α is regulated by mTOR and is considered as a substantial molecule for adaptation of cells to stress like hypoxia by regulating hundreds of genes. Essential processes which include autophagy, apoptosis, glucose delivery and glycolysis are regulated in large via HIF1-α. Consequently, HIF1-α is implicated to be of relevance in several medical settings, consisting of tumor growth and development. In hypoxia, mTOR is inactivated, which is assumed to be a part of cells program to keep energy homeostasis. Therefore, it seems, maybe rapamycin affects tumor cell death in mTOR-independent pathways.[@CIT0033]--[@CIT0036]Figure 6Rapamycin induces cervical cancer cell death in hypoxia more than normoxia.

Conclusion {#S0005}
==========

Our results indicated the main role for rapamycin in autophagy and apoptosis induction in normoxia and hypoxia. These findings showed that rapamycin may be a promising strategy for the treatment of cervical cancer. The critical reaction to rapamycin can be extensively influenced via mobile intrinsic (genotype and cell cycle) and extrinsic factors (dosage, stimulation time, oxygen and nutrient availability). The findings provide a new evidence that autophagy may inhibit the HeLa cell viability under hypoxia through the trigger of PCD, facilitating the development of novel anti-cancer therapy. It can be a main strategy for the cervical cancer treatment by modulating the expression of Atgs and Bcl-2 family proteins, especially in hypoxia-tumor cells. However, studying other cervical cancer cell lines, as well as in-vivo studies, is necessary.
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=============
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[^1]: **Abbreviations:** F, forward; R, reverse.
